FIELD: medicine, pharmacy. SUBSTANCE: composition has a mixture of hydroxyethylated lanolin and interleukin-1 as an active component at the following ratio of components in the final agent, wt.-%: hydroxyethylated lanolin 0.04-25; interleukin-1 10-5-5•10-7; water or isotonic solution 1.96-25, and ointment base 74.6-98. An active component can contain additionally 0.09-1.0 wt.-% anesthesin. Lanolin, Vaseline, Vaseline oil, wool wax alcohols are used as an ointment base. Composition is used for treatment sluggish healing wounds, ulcers and complicated by suppurative-inflammatory processes. EFFECT: enhanced effectiveness of composition. 4 cl, 5 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
WOUND-HEALING COMPOSITION | 1999 |
|
RU2169004C1 |
WOUND HEALING OINTMENT FOR THE TREATMENT OF THERMAL BURNS | 2022 |
|
RU2787377C1 |
COMPOSITION FOR WOUND AND BURN TREATMENT | 1999 |
|
RU2164133C2 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
HUMAN INTERLEUKIN-2 BASE ANTITUMOR AGENT SHOWING LOCAL-RESORPTIVE EFFECT | 1995 |
|
RU2117472C1 |
PREPARATION FOR TREATMENT OF SLUGGISH WOUND AND TROPHIC ULCER (VARIANTS) | 1998 |
|
RU2148989C1 |
Authors
Dates
1998-11-27—Published
1993-12-16—Filed